Every day, more than 2,500 Americans die from cardiovascular diseases (CVD) – heart attacks, strokes, sudden cardiac arrest, among others. CVD is the most common cause of morbidity and mortality in the U.S. and around the globe. But many more Americans and their families work to reduce the causes, symptoms, and consequences of cardiovascular disease across populations. In recognition of American Heart Month month, this week we highlight the innovative science of three UW School of Nursing investigators to reduce CVD across settings. As we reflect on their scientific contributions, one consistent theme emerges – the unwavering dedication of nurse scientists to amplify the voices and experiences of those living with or affected by heart disease.
Assistant Professor, Alexi Vasbinder PhD, RN studies cancer survivors in the United States, particularly those who have or are preparing to undergo a bone marrow transplant which increases their risk of cardiovascular complications and long-term cardiovascular disease. Alexi says she is “passionate about this work because these individuals have already fought so hard for their health, and I want to help ensure they live long, healthy lives beyond cancer.” Her work, which has been published in various high-impact scientific journals, seeks to inform clinical guidelines for tailored treatment, monitoring, and prevention strategies for cardiovascular complications in cancer survivors. By identifying cancer survivors at the highest risk for CVD, Alexi’s work is laying the foundation for personalized interventions to catch heart issues early, provide better long-term monitoring, and ultimately prevent cardiovascular disease in this vulnerable and resilient population.
Similarly, as people increasingly develop multiple chronic health diseases, UW School of Nursing investigators are trying to develop novel interventions to help patients manage their cardiovascular risk factors using patient-centered strategies. Research Assistant Professor, Vitor Oliveira was recently awarded one of the School’s RIFP grants to conduct a Proof-of-concept study developing a behavioral intervention to improve the cardiovascular health of people living with HIV. Motivating this work, Vitor notes that “today HIV is treated as a chronic condition and cardiovascular disease is the leading cause of death among these patients.” He is dedicated to shedding light on these often overlooked co-occurring health issues by generating novel evidence in studies funded by NIH, NORC and many other sponsors. His goal is to empower this population with the knowledge of how to effectively use lifestyle interventions, like physical activity and nutritional supplements, to combat heart disease.
In Mozambique, Professor Sarah Gimble is exploring ways to reduce high blood pressure in adults living with HIV in low-income settings. She emphasizes the dual importance of this issue: high blood pressure is widespread, and HIV care is the only chronic healthcare platform in Sub-Saharan Africa. Her team believes that integrating other chronic diseases into this platform is efficient and could create a scalable model for the entire population. Sarah encapsulates the impact of her research by stating, ‘Cardiovascular health is crucial for everyone. When properly managed, it can mitigate numerous other illnesses.’ Her work, along with the work of Drs Vasbinder and Oliveira, underscore the transformative potential of prioritizing heart health, not just for individuals, but for entire communities in the United States and throughout the world.